I make a donation

AEGEAN

To assess the impact of an educational program on patient adherence in patients taking apixaban for stroke prevention in atrial fibrillation

Terminée

Remerciements de la Famille COLLET

Prix de Recherche Pr Jean-Philippe COLLET

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

objectif

The study purpose is to assess the impact of an educational program on patient adherence in patients taking Apixaban for SPAF at 24 weeks

date de réalisation

2013

nombre de patients

1217

nombre de centres participants

International multicentric trial

type de financement

Private (BMS)

Référence

NCT01884350

Publications

Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial
Gilles Montalescot, Carlos Brotons, Bernard Cosyns, Harry J Crijns, Armando D'Angelo, Ludovic Drouet, Franz Eberli, Deirdre A Lane, Bruno Besse, Anthony Chan, Eric Vicaut, Harald Darius, AEGEAN Study Investigators
Publié dans American Journal of Cardiovascular Drugs

Autres études

ARAMIS

En cours

Evaluation of Anakinra versus placebo in treatment of acute myocarditis and evaluation of the contuity of the reference treatment with IEC in patients without ventricular dysfunction ventriculaire.

AFIJI

En cours

Impact of genetics on occuring of coronary diseases in young patients and the pharmacogenetic of clopidogrel and its impact on the prognosis of patients having had angioplasty

BIO-TAVI

En cours

Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI